ArticleJournal of thoracic disease2024

Atezolizumab and nintedanib in patients with non-small cell lung cancer and interstitial lung disease.

Teppei Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.